BIM
NXTC icon

Bogle Investment Management’s NextCure NXTC Stock Holding History

Bogle Investment Management’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,857
Closed -$374K – 75
2020
Q4 		$374K Buy
2,857
+492
+21% +$63.6K 0.59% 85
2020
Q3 		$250K Buy
+2,365
New +$291K 0.07% 214

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Bogle Investment Management's NXTC Position: Q1 2021 in Review

Bogle Investment Management sold out of NextCure (NXTC) in Q1 2021, closing a stake of 2,857 shares — an estimated $374K sold.

Bogle Investment Management first reported a position in NXTC in Q3 2020 and held it in 2 quarters. The position peaked at $374K in Q4 2020. 92 funds tracked by Wall St. Rank hold NXTC as of Q1 2021.

  • Bogle Investment Management reported no remaining NextCure position as of Q1 2021 after selling out during the quarter.
  • Bogle Investment Management sold 2,857 NextCure shares in Q1 2021, an estimated $374K.
  • Bogle Investment Management first reported a position in NextCure in Q3 2020 and held it in 2 quarters.
  • Bogle Investment Management's NextCure position peaked at $374K in Q4 2020.
  • 92 funds tracked by Wall St. Rank held NextCure as of Q1 2021.

Based on Bogle Investment Management's 13F filing for Q1 2021.